Personal information

Emails & domains

Verified email domains

Activities

Collapse all

Employment (1)

Fred Hutchinson Cancer Research Center: Seattle, WA, US

Employment
Source: check_circle
Fred Hutchinson Cancer Center

Works (39)

Cancer in rural America: Improving access to clinical trials and quality of oncologic care

CA: A Cancer Journal for Clinicians
2025-03-27 | Journal article
DOI: 10.3322/caac.70006
Contributors: Joseph M. Unger; Barbara L. McAneny; Raymond U. Osarogiagbon
Source: check_circle
Crossref

When to adjust for multiplicity in cancer clinical trials

JNCI Monographs
2025-03-01 | Journal article
DOI: 10.1093/jncimonographs/lgae051
Contributors: Joseph M Unger; Gina L Mazza; Mohamed I Elsaid; Fenhai Duan; Emily V Dressler; Anna C Snavely; Danielle M Enserro; Stephanie L Pugh
Source: check_circle
Crossref

Financial toxicity: A ubiquitous condition in patients with cancer

Cancer
2025-02-15 | Journal article
DOI: 10.1002/cncr.35748
Contributors: Joseph M. Unger
Source: check_circle
Crossref

Patient Enrollment to Industry-Sponsored Versus Federally-Sponsored Cancer Clinical Trials

Journal of Clinical Oncology
2024-11-20 | Journal article
DOI: 10.1200/JCO.24.00843
Contributors: Joseph M. Unger; Hong Xiao; Riha Vaidya; Michael LeBlanc
Source: check_circle
Crossref

National Estimates of the Participation of Patients With Cancer in Clinical Research Studies Based on Commission on Cancer Accreditation Data

Journal of Clinical Oncology
2024-06-20 | Journal article
DOI: 10.1200/JCO.23.01030
Contributors: Joseph M. Unger; Lawrence N. Shulman; Matthew A. Facktor; Heidi Nelson; Mark E. Fleury
Source: check_circle
Crossref

Impact of Broadening Trial Eligibility Criteria on the Inclusion of Patients With Brain Metastases in Cancer Clinical Trials: Time Series Analyses for 2012-2022

Journal of Clinical Oncology
2024-06-01 | Journal article
DOI: 10.1200/JCO.23.01777
Contributors: Hong Xiao; Riha Vaidya; Dawn L. Hershman; Joseph M. Unger
Source: check_circle
Crossref

Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data Quality

JCO Oncology Practice
2023-10 | Journal article
DOI: 10.1200/OP.23.00185
Contributors: Joseph M. Unger; Hillary Stires; Laura A. Levit; Mark Stewart; Brittany Avin McKelvey; Beverly Canin; Emily Dressler; Keith Flaherty; Peter Fredette; Lee Jones et al.
Source: check_circle
Crossref

Dynamic zero-COVID policy and healthcare utilization patterns in China during the Shanghai COVID-19 Omicron outbreak

Communications Medicine
2023-10-11 | Journal article
DOI: 10.1038/s43856-023-00375-w
Contributors: Hong Xiao; Fang Liu; Joseph M. Unger
Source: check_circle
Crossref

Representativeness of Patients Enrolled in the Lung Cancer Master Protocol (Lung-MAP)

JCO Precision Oncology
2023-09 | Journal article
DOI: 10.1200/PO.23.00218
Contributors: Riha Vaidya; Joseph M. Unger; Lu Qian; Katherine Minichiello; Roy S. Herbst; David R. Gandara; Joel W. Neal; Ticiana A. Leal; Jyoti D. Patel; Konstantin H. Dragnev et al.
Source: check_circle
Crossref

Data from Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation

2023-09-28 | Preprint
DOI: 10.1158/2767-9764.c.6856589
Contributors: Riha Vaidya; Joseph M. Unger; Rohit Loomba; Jessica P. Hwang; Rashmi Chugh; Monica A. Tincopa; Kathryn B. Arnold; Dawn L. Hershman; Scott D. Ramsey
Source: check_circle
Crossref

Data from Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation

2023-09-28 | Preprint
DOI: 10.1158/2767-9764.c.6856589.v1
Contributors: Riha Vaidya; Joseph M. Unger; Rohit Loomba; Jessica P. Hwang; Rashmi Chugh; Monica A. Tincopa; Kathryn B. Arnold; Dawn L. Hershman; Scott D. Ramsey
Source: check_circle
Crossref

FIGURE 1 from Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation

2023-09-28 | Preprint
DOI: 10.1158/2767-9764.24212558
Contributors: Riha Vaidya; Joseph M. Unger; Rohit Loomba; Jessica P. Hwang; Rashmi Chugh; Monica A. Tincopa; Kathryn B. Arnold; Dawn L. Hershman; Scott D. Ramsey
Source: check_circle
Crossref

FIGURE 1 from Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation

2023-09-28 | Preprint
DOI: 10.1158/2767-9764.24212558.v1
Contributors: Riha Vaidya; Joseph M. Unger; Rohit Loomba; Jessica P. Hwang; Rashmi Chugh; Monica A. Tincopa; Kathryn B. Arnold; Dawn L. Hershman; Scott D. Ramsey
Source: check_circle
Crossref

TABLE 1 from Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation

2023-09-28 | Preprint
DOI: 10.1158/2767-9764.24212555
Contributors: Riha Vaidya; Joseph M. Unger; Rohit Loomba; Jessica P. Hwang; Rashmi Chugh; Monica A. Tincopa; Kathryn B. Arnold; Dawn L. Hershman; Scott D. Ramsey
Source: check_circle
Crossref

TABLE 1 from Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation

2023-09-28 | Preprint
DOI: 10.1158/2767-9764.24212555.v1
Contributors: Riha Vaidya; Joseph M. Unger; Rohit Loomba; Jessica P. Hwang; Rashmi Chugh; Monica A. Tincopa; Kathryn B. Arnold; Dawn L. Hershman; Scott D. Ramsey
Source: check_circle
Crossref

TABLE 2 from Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation

2023-09-28 | Preprint
DOI: 10.1158/2767-9764.24212552
Contributors: Riha Vaidya; Joseph M. Unger; Rohit Loomba; Jessica P. Hwang; Rashmi Chugh; Monica A. Tincopa; Kathryn B. Arnold; Dawn L. Hershman; Scott D. Ramsey
Source: check_circle
Crossref

TABLE 2 from Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation

2023-09-28 | Preprint
DOI: 10.1158/2767-9764.24212552.v1
Contributors: Riha Vaidya; Joseph M. Unger; Rohit Loomba; Jessica P. Hwang; Rashmi Chugh; Monica A. Tincopa; Kathryn B. Arnold; Dawn L. Hershman; Scott D. Ramsey
Source: check_circle
Crossref

TABLE 3 from Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation

2023-09-28 | Preprint
DOI: 10.1158/2767-9764.24212549
Contributors: Riha Vaidya; Joseph M. Unger; Rohit Loomba; Jessica P. Hwang; Rashmi Chugh; Monica A. Tincopa; Kathryn B. Arnold; Dawn L. Hershman; Scott D. Ramsey
Source: check_circle
Crossref

TABLE 3 from Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation

2023-09-28 | Preprint
DOI: 10.1158/2767-9764.24212549.v1
Contributors: Riha Vaidya; Joseph M. Unger; Rohit Loomba; Jessica P. Hwang; Rashmi Chugh; Monica A. Tincopa; Kathryn B. Arnold; Dawn L. Hershman; Scott D. Ramsey
Source: check_circle
Crossref

Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation

Cancer Research Communications
2023-09-28 | Journal article
DOI: 10.1158/2767-9764.CRC-23-0255
Contributors: Riha Vaidya; Joseph M. Unger; Rohit Loomba; Jessica P. Hwang; Rashmi Chugh; Monica A. Tincopa; Kathryn B. Arnold; Dawn L. Hershman; Scott D. Ramsey
Source: check_circle
Crossref

Risk prediction of hepatitis B or C or HIV among newly diagnosed cancer patients

JNCI: Journal of the National Cancer Institute
2023-06-08 | Journal article
DOI: 10.1093/jnci/djad053
Contributors: Joseph M Unger; Cathee Till; Jessica P Hwang; Kathryn B Arnold; Michael Leblanc; Dawn L Hershman; Scott D Ramsey
Source: check_circle
Crossref

Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG)

JCO Clinical Cancer Informatics
2023-04 | Journal article
DOI: 10.1200/CCI.22.00165
Contributors: Shing M. Lee; Weijia Fan; Aijin Wang; Riha Vaidya; Mary W. Redman; Scott N. Gettinger; Lyudmila Bazhenova; Roy S. Herbst; Dawn L. Hershman; Joseph M. Unger
Source: check_circle
Crossref

Quality-of-life outcomes and risk prediction for patients randomized to nivolumab plus ipilimumab vs nivolumab on LungMAP-S1400I

JNCI: Journal of the National Cancer Institute
2023-04-11 | Journal article
DOI: 10.1093/jnci/djad003
Contributors: Joseph M Unger; Lu Qian; Mary W Redman; Susan S Tavernier; Lori Minasian; Ellen V Sigal; Vassiliki A Papadimitrakopoulou; Michael Leblanc; Charles S Cleeland; Samuel A Dzingle et al.
Source: check_circle
Crossref

Population, Clinical, and Scientific Impact of National Cancer Institute's National Clinical Trials Network Treatment Studies

Journal of Clinical Oncology
2023-04-10 | Journal article
DOI: 10.1200/JCO.22.01826
Contributors: Joseph M. Unger; Michael LeBlanc; Suzanne George; Norman Wolmark; Walter J. Curran, Jr; Peter J. O'Dwyer; Mitchell D. Schnall; Robert S. Mannel; Sumithra J. Mandrekar; James J. Dignam et al.
Source: check_circle
Crossref

Sex Differences in Risk of Severe Adverse Events in Patients Receiving Immunotherapy, Targeted Therapy, or Chemotherapy in Cancer Clinical Trials

Journal of Clinical Oncology
2022-05-01 | Journal article
DOI: 10.1200/JCO.21.02377
Contributors: Joseph M. Unger; Riha Vaidya; Kathy S. Albain; Michael LeBlanc; Lori M. Minasian; Carolyn C. Gotay; N. Lynn Henry; Michael J. Fisch; Shing M. Lee; Charles D. Blanke et al.
Source: check_circle
Crossref

Association Between Health-Related Quality of Life and Progression-Free Survival in Patients With Advanced Cancer: A Secondary Analysis of SWOG Clinical Trials

JCO Oncology Practice
2022-04 | Journal article
DOI: 10.1200/OP.21.00407
Contributors: David Hui; Amy K. Darke; Katherine A. Guthrie; Ishwaria M. Subbiah; Joseph M. Unger; Dawn L. Hershman; Robert S. Krouse; Marie Bakitas; Mark A. O'Rourke
Source: check_circle
Crossref

S1417CD: A Prospective Multicenter Cooperative Group-Led Study of Financial Hardship in Metastatic Colorectal Cancer Patients

JNCI: Journal of the National Cancer Institute
2022-03-08 | Journal article
DOI: 10.1093/jnci/djab210
Contributors: Veena Shankaran; Joseph M Unger; Amy K Darke; Jennifer Marie Suga; James L Wade, III; Peter J Kourlas; Sreenivasa R Chandana; Mark A O’Rourke; Suma Satti; Diane Liggett et al.
Source: check_circle
Crossref

The COVID-19 pandemic and new clinical trial activations

Trials
2021-12 | Journal article
DOI: 10.1186/s13063-021-05219-3
Contributors: Joseph M. Unger; Hong Xiao
Source: check_circle
Crossref

Adolescent and young adult enrollment to a National Cancer Institute–sponsored National Clinical Trials Network Research Group over 25 years

Cancer
2021-12-15 | Journal article
DOI: 10.1002/cncr.33855
Contributors: Joseph M. Unger; Melissa Beauchemin; Dawn L. Hershman
Source: check_circle
Crossref

Predictors of Pain Reduction in Trials of Interventions for Aromatase Inhibitor–Associated Musculoskeletal Symptoms

JNCI Cancer Spectrum
2021-11-03 | Journal article
DOI: 10.1093/jncics/pkab087
Contributors: N Lynn Henry; Joseph M Unger; Cathee Till; Katherine D Crew; Michael J Fisch; Dawn L Hershman
Source: check_circle
Crossref

Association of Fatigue and Outcomes in Advanced Cancer: An Analysis of Four SWOG Treatment Trials

JCO Oncology Practice
2021-08 | Journal article
DOI: 10.1200/OP.20.01096
Contributors: Julia Mo; Amy K. Darke; Katherine A. Guthrie; Jeff A. Sloan; Joseph M. Unger; Dawn L. Hershman; Mark O'Rourke; Marie Bakitas; Robert S. Krouse
Source: check_circle
Crossref

Patient-Reported Outcomes and Long-Term Nonadherence to Aromatase Inhibitors

JNCI: Journal of the National Cancer Institute
2021-08-02 | Journal article
DOI: 10.1093/jnci/djab022
Contributors: Dawn L Hershman; Alfred I Neugut; Anna Moseley; Kathryn B Arnold; Julie R Gralow; N Lynn Henry; Grace Clarke Hillyer; Scott D Ramsey; Joseph M Unger
Source: check_circle
Crossref

Persistent Disparity: Socioeconomic Deprivation and Cancer Outcomes in Patients Treated in Clinical Trials

Journal of Clinical Oncology
2021-04-20 | Journal article
DOI: 10.1200/JCO.20.02602
Contributors: Joseph M. Unger; Anna B. Moseley; Christabel K. Cheung; Raymond U. Osarogiagbon; Banu Symington; Scott D. Ramsey; Dawn L. Hershman
Source: check_circle
Crossref

Current Practices for Screening and Addressing Financial Hardship within the NCI Community Oncology Research Program

Cancer Epidemiology, Biomarkers & Prevention
2021-04-01 | Journal article
DOI: 10.1158/1055-9965.EPI-20-1157
Contributors: Laurie E. McLouth; Chandylen L. Nightingale; Emily V. Dressler; Anna C. Snavely; Matthew F. Hudson; Joseph M. Unger; Anne E. Kazak; Simon J. Craddock Lee; Jean Edward; Ruth Carlos et al.
Source: check_circle
Crossref

Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare

Blood Cancer Discovery
2021-03-01 | Journal article
DOI: 10.1158/2643-3230.BCD-20-0123
Contributors: Nicole Gormley; Lola Fashoyin-Aje; Trevan Locke; Joseph M. Unger; Richard F. Little; Ajay Nooka; Khalid Mezzi; Mihaela Popa-McKiver; Rachel Kobos; Yelak Biru et al.
Source: check_circle
Crossref

“When Offered to Participate”: A Systematic Review and Meta-Analysis of Patient Agreement to Participate in Cancer Clinical Trials

JNCI: Journal of the National Cancer Institute
2021-03-01 | Journal article
DOI: 10.1093/jnci/djaa155
Contributors: Joseph M Unger; Dawn L Hershman; Cathee Till; Lori M Minasian; Raymond U Osarogiagbon; Mark E Fleury; Riha Vaidya
Source: check_circle
Crossref

The COVID-19 Pandemic and New Clinical Trial Activations

2021-01-18 | Preprint
DOI: 10.21203/rs.3.rs-146767/v1
Contributors: Joseph Unger; Hong Xiao
Source: check_circle
Crossref

Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies

JNCI Cancer Spectrum
2020-08-01 | Journal article
DOI: 10.1093/jncics/pkaa034
Contributors: Joseph M Unger; Dawn L Hershman; Raymond U Osarogiagbon; Anirudh Gothwal; Seerat Anand; Arvind Dasari; Michael Overman; Jonathan M Loree; Kanwal Raghav
Source: check_circle
Crossref

The scientific impact and value of large, NCI-sponsored randomized phase III cancer chemoprevention trials

Cancer Epidemiology
2018-08 | Journal article
DOI: 10.1016/j.canep.2018.06.005
Contributors: Joseph M. Unger; William E. Barlow; Catherine M. Tangen; Scott D. Ramsey; Ian M. Thompson, Jr.; Eric A. Klein; Michael LeBlanc; Charles D. Blanke; Phyllis J. Goodman; Lori M. Minasian et al.
Source: check_circle
Crossref

Peer review (21 reviews for 13 publications/grants)

Review activity for Annals of epidemiology. (1)
Review activity for BMC medicine (1)
Review activity for Breast cancer research and treatment. (2)
Review activity for Cancer causes & control. (1)
Review activity for Contemporary clinical trials communications. (1)
Review activity for Journal of clinical epidemiology. (2)
Review activity for Journal of racial and ethnic health disparities. (1)
Review activity for Journal of the National Cancer Institute : (3)
Review activity for Nature communications (2)
Review activity for Nature medicine. (2)
Review activity for NPJ breast cancer. (2)
Review activity for PLoS medicine. (1)
Review activity for PloS one. (2)
How many people are using ORCID?